CARLSMED INC (CARL) — insider trading
Health Care · NASDAQ
CARLSMED INC (CARL) has 49 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases and 3 open-market sales among the most recent 49 (latest 2026-10-05).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 747 | — | $0 | Form 4 |
| 2026-10-05 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Open-market sale | 747 | $14.39 | $10.7K | Form 4 |
| 2026-10-05 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Option exercise / conversion | 747 | $5.92 | $4.4K | Form 4 |
| 2026-09-30 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 243 | — | $0 | Form 4 |
| 2026-09-30 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Open-market sale | 243 | $13.99 | $3.4K | Form 4 |
| 2026-09-30 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Option exercise / conversion | 243 | $2.23 | $542 | Form 4 |
| 2026-09-28 | Heppenstall Richard | Officer (CFO, Treasurer) | Grant / award / vesting (derivative) | 180,137 | — | $0 | Form 4 |
| 2026-09-28 | Heppenstall Richard | Officer (CFO, Treasurer) | Grant / award / vesting | 89,286 | — | $0 | Form 4 |
| 2026-09-08 | Bertolini Jeffrey | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 50,000 | — | $0 | Form 4 |
| 2026-06-03 | YOUNG PHILIP M | Director | Grant / award / vesting | 13,698 | — | $0 | Form 4 |
| 2026-06-03 | ROOT JONATHAN D | Director | Grant / award / vesting | 13,698 | — | $0 | Form 4 |
| 2026-06-03 | Sidow Kevin | Director | Grant / award / vesting | 13,698 | — | $0 | Form 4 |
| 2026-06-03 | OBOYLE KEVIN C | Director | Grant / award / vesting | 13,698 | — | $0 | Form 4 |
| 2026-03-03 | Cordonnier Michael | Director, Officer (CEO, President) | Option exercise / conversion (derivative) | 33,264 | — | $0 | Form 4 |
| 2026-03-03 | Cordonnier Michael | Director, Officer (CEO, President) | Option exercise / conversion (derivative) | 160,567 | — | $0 | Form 4 |
| 2026-03-03 | Cordonnier Michael | Director, Officer (CEO, President) | Option exercise / conversion | 33,264 | $4.35 | $144.8K | Form 4 |
| 2026-03-03 | Cordonnier Michael | Director, Officer (CEO, President) | Option exercise / conversion | 160,567 | $0.335 | $53.8K | Form 4 |
| 2026-03-02 | Cordonnier Michael | Director, Officer (CEO, President) | Option exercise / conversion (derivative) | 197,855 | — | $0 | Form 4 |
| 2026-03-02 | Cordonnier Michael | Director, Officer (CEO, President) | Open-market sale | 197,855 | $13.29 | $2.63M | Form 4 |
| 2026-03-02 | Cordonnier Michael | Director, Officer (CEO, President) | Option exercise / conversion | 197,855 | $0.335 | $66.3K | Form 4 |
| 2026-01-28 | Greenstein Leonard M. | Officer (CFO, Treasurer) | Grant / award / vesting | 44,977 | — | $0 | Form 4 |
| 2026-01-28 | Cordonnier Michael | Director, Officer (CEO, President) | Grant / award / vesting | 117,316 | — | $0 | Form 4 |
| 2026-01-28 | Casey Niall | Director, Officer (Chief IP Officer) | Grant / award / vesting | 44,977 | — | $0 | Form 4 |
| 2026-01-28 | Durall William Scott | Officer (Chief Commercial Officer) | Grant / award / vesting | 44,977 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Open-market purchase | 200,000 | $15.00 | $3.00M | Form 4/A |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 1,117,743 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 26,993 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 41,876 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 149,655 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 531,877 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 825,135 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative (derivative) | 2,948,794 | — | $0 | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 1,117,743 | — | — | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 26,993 | — | — | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 41,876 | — | — | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 149,655 | — | — | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 531,877 | — | — | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 825,135 | — | — | Form 4 |
| 2025-07-24 | Presidio Management Group XII, L.L.C.; U.S. Venture Partners XII, L.P.; Tansey Casey M | 10% owner | Conversion of derivative | 2,948,794 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative (derivative) | 931,452 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative (derivative) | 931,452 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative (derivative) | 1,445,020 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative (derivative) | 2,235,486 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative (derivative) | 1,445,020 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative | 931,452 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative | 2,376,472 | — | — | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Open-market purchase | 1,333,333 | $15.00 | $20.00M | Form 4 |
| 2025-07-24 | B CAPITAL GROUP MANAGEMENT, L.P.; B Capital Global Growth III, L.P.; B Capital Healthcare I, L.P.; Hornet Co-Invest Investors, Ltd.; Hornet Co-Invest, LP | 10% owner | Conversion of derivative | 3,680,506 | — | — | Form 4 |
| 2025-07-22 | Durall William Scott | Officer (Chief Commercial Officer) | Grant / award / vesting (derivative) | 71,429 | — | $0 | Form 4 |
Ask the chat about CARL's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CARLSMED INC (CARL).
Last updated 2026-10-05 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.